Luminate Medical

Luminate Medical, founded in 2019, develops technology to prevent the side effects of chemotherapy and enable at-home cancer treatment, operating within the medical devices and cancer treatment technology domains.

The company's product portfolio includes Lily, which prevents hair loss during chemotherapy; Lotus, which enables at-home infusions for cancer treatment; and Lilac, which prevents peripheral neuropathy. These devices address specific challenges in oncology care.

With operations in Galway, Ireland, and the United States, Luminate Medical has secured over 30 million euros in funding. It works across the oncology, MedTech, and healthcare technology verticals.

The company maintains a patient-centric, collaborative, and mission-driven approach, focusing on human-centered care in its medical innovation efforts.